Cevostamab [2249888-53-5]

TargetMol Chemicals

Cevostamab

9

2249888-53-5

Antibody

Research Use Only

Cevostamab

Cevostamab (BFCR4350A; RG6160; RO7187797), a humanized IgG1-based bi-specific antibody (BsAb), specifically targets the membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells and CD3 on T cells. It enhances synapse formation and augments T cell-mediated killing of MM tumor cells [1] [2].

3 years

-20°C

12352203